A novel recombinant 6Aß15-THc-C chimeric vaccine (rCV02) mitigates Alzheimer's disease-like pathology, cognitive decline and synaptic loss in aged 3 × Tg-AD mice.

Yu, Yun-Zhou; Liu, Si; Wang, Hai-Chao; Shi, Dan-Yang; Xu, Qing; Zhou, Xiao-Wei; Sun, Zhi-Wei; Huang, Pei-Tang

Yu, Yun-Zhou; Liu, Si; Wang, Hai-Chao; Shi, Dan-Yang; Xu, Qing; Zhou, Xiao-Wei; Sun, Zhi-Wei; Huang, Pei-Tang.

Affiliation

Yu YZ; Beijing Institute of Biotechnology, Beijing 100071, China.
Liu S; Beijing Institute of Biotechnology, Beijing 100071, China.
Wang HC; Beijing Institute of Biotechnology, Beijing 100071, China.
Shi DY; Institute of Life Science and Biotechnology, Beijing Jiaotong University, Beijing 100044, China.
Xu Q; Beijing Institute of Biotechnology, Beijing 100071, China.
Zhou XW; Institute of Life Science and Biotechnology, Beijing Jiaotong University, Beijing 100044, China.
Sun ZW; Beijing Institute of Biotechnology, Beijing 100071, China.
Huang PT; Beijing Institute of Biotechnology, Beijing 100071, China.

Sci Rep ; 6: 27175, 2016 06 03.

Article de En | MEDLINE | ID: mdl-27255752

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Peptides bêta-amyloïdes / Cognition / Vaccins contre la maladie d'Alzheimer / Maladie d'Alzheimer Limites: Animals Langue: En Journal: Sci Rep Année: 2016 Type de document: Article Pays d'affiliation: Chine Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google